Sector & Market
Larimar Therapeutics Insider Purchase Boosts Stock 15.5%
Larimar Therapeutics shares rose about 15.5% after director Thomas Edward Hamilton bought 50,000 common shares.
The purchase was made at a weighted average price of $3.3378 per share, with transaction
